Mundipharma’s president of Asia Pacific, Latin America, and the Middle East and Africa, Raman Singh defines the underlying drivers behind the company’s explosive growth, while sharing his insights on what it takes for pharma companies to truly succeed in modern-day emerging markets. He also elaborates on Mundipharma’s recent decision to establish its very first integrated manufacturing and R&D consumer health hub in Singapore and how it seamlessly aligns with the country’s core capabilities. Although only stepping into this role in 2011, we see that the business has already undergone a massive transformation. What would you summarize as the most notable achievements in these last five years overseeing emerging markets?
Since 2011, our presence has grown from six markets to 122 in the emerging world.